Repurposing Valsartan May Protect Against Pulmonary Hypertension

Conditions:   Pulmonary Arterial Hypertension;   Right Heart Failure;   Right Ventricular Dysfunction;   Pulmonary Vascular Disorder Interventions:   Drug: Valsartan 40 mg;   Drug: Placebo Sponsors:   University of Washington;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials